Skin Cancer

Personalized Cancer Vaccine Shows Long-Term Survival for Patients with High-Risk Melanoma
August 06, 2020

Data released from a phase 2b clinical trial showed statistically significant long-term survival for patients with stage III or IV melanoma at high-risk of recurrence.

FDA Approves Pembrolizumab for Cutaneous Squamous Cell Carcinoma
June 24, 2020

The FDA approved pembrolizumab for patients with recurrent or metastatic cutaneous squamous cell carcinoma that is not curable by surgery or radiation.

Increases in Melanoma Risk in Patients Treated with Biologic Therapy Not Ruled Out
May 25, 2020

Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot yet be ruled out based on current evidence.